Despite current studies pointing to the fact that CCND1 is overexpressed and activated in a variety of cancers [46], few reports discuss the underlying molecular mechanisms by which CCND1 is regulated or activated in malignant tumors, especially in FGFR1 amplified lung cancer. Here, FGFR1 is linked to lung cancer.